Mkt Cap$2.23T-1.74%
24h Vol$74.28B
BTC Dom56.3%
ETH Dom9.0%
F&G17Extreme Fear
BTC$62,686.00-1.67% ETH$1,666.62-3.16% USDT$0.9987-0.01% BNB$577.36-1.84% USDC$0.9996-0.01% XRP$1.10-1.88% SOL$69.40-3.23% TRX$0.329-1.01% FIGR_HELOC$1.03-0.16% HYPE$61.30-7.24% DOGE$0.0789-3.56% USDS$0.9997+0.00% RAIN$0.0157-2.06% LEO$9.49-0.84% ZEC$413.84-6.89% XLM$0.1911-3.05% BTC$62,686.00-1.67% ETH$1,666.62-3.16% USDT$0.9987-0.01% BNB$577.36-1.84% USDC$0.9996-0.01% XRP$1.10-1.88% SOL$69.40-3.23% TRX$0.329-1.01% FIGR_HELOC$1.03-0.16% HYPE$61.30-7.24% DOGE$0.0789-3.56% USDS$0.9997+0.00% RAIN$0.0157-2.06% LEO$9.49-0.84% ZEC$413.84-6.89% XLM$0.1911-3.05%
News

Glenview Capital

Total Stories
1
Section
Glenview Capital
CVS Faces Potential Activist Pressure Following Share Price Drop
Market Analysis

CVS Faces Potential Activist Pressure Following Share Price Drop

Hedge fund Glenview Capital plans to meet with CVS Health executives to propose operational changes amid the company's struggling stock performance and financial challenges.

Tim FriesSep 30, 20242 min read